in

US EPA finalizes list of 20 low-priority chemicals

Substances will not undergo further evaluation of health and safety risks at this time




in

23 minerals at risk of US supply shortages, study shows




in

DSM to enter human milk oligosaccharide market by acquiring Glycom

$830 million deal builds on earlier moves into nutritional ingredients




in

ACS Career Days program brings career resources to the community

Society hosts professional development events in cities across the US




in

Mitsubishi Gas Chemical plans peroxide plant in Taiwan




in

Paul Turgeon taking the helm at MFG Chemical




in

Audentes to build gene therapy plant in North Carolina




in

Ethylene plants start up in the US




in

Sanofi, BARDA team for coronavirus vaccine




in

N<sub>2</sub>O no laughing matter for Lonza in Visp




in

Superefficient solar desalination

System harnesses waste heat to produce enough drinkable water for an adult in 1 h




in

45Q, the tax credit that's luring US companies to capture CO<sub>2</sub>

Cement, ethanol, and ammonia makers are among those looking to convert waste carbon to cash




in

Hemp growing pains

US regulatory uncertainty threatens to cripple the nascent industry's ability to meet the surge in demand for cannabidiol




in

Your guide to the ACS Spring 2020 National Meeting in Philadelphia

C&EN's editors pick the speakers and symposia to catch




in

Periodic Graphics: Cannabidiol, medicine from hemp

Chemical educator and <i>Compound Interest</i> blogger Andy Brunning explains the CBD craze, how the compound works, and how it's regulated.




in

Should the chemical industry have to prove it can pay for pollution cleanup?

No, US EPA says in proposal




in

Groups sue US military to stop PFAS incineration

Activists say contracts with companies violate federal law




in

Sanofi to create new firm from its drug-making facilities

Venture will combine six active pharmaceutical ingredient production sites in Europe




in

Molded microfluidic device makes gel &#8220;apartments&#8221; for single cells

Hydrogel device allows localized treatment and analysis of 10,000 individual cells at a time




in

AI finds molecules that kill bacteria, but would they make good antibiotics?

Experts praise the approach while remaining skeptical that the highlighted molecules could reach the clinic




in

Pauling's rules about crystal structures flunk test

Only 13 % of oxide crystal structures obey 4 of the 5 rules simultaneously




in

Turning down the heat turns up better perovskites

Lower-temperature process improves the efficiency of single-crystal solar cells




in

Chemistry in Pictures: Tinsel town




in

Wonyong Choi to lead &lt;i&gt;ACS ES&amp;T Engineering&lt;/i&gt;

Inaugural editor in chief will focus on emerging and interdisciplinary areas of environmental engineering




in

How to make aziridines from olefins without expensive metals

Double bonds form nitrogen-containing 3-membered rings thanks to a reactive, yet fleeting, oxaziridine intermediate




in

Free-floating electrocatalysts outperform tethered ones

Detaching particles from the electrode surface frees them from electrical fatigue




in

China's new place on the front lines of diagnosing and treating coronavirus disease

Industry watchers say the effort is unprecedented and would not have been possible during the last SARS outbreak




in

Genetic signature links bacterial toxin to colon cancer

Colibactin causes key cancer mutations




in

Biogen bets big on Sangamo's zinc fingers to treat Alzheimer's

Biogen will pay the biotech firm $350 million upfront and get rights to its therapies for up to 12 neurological diseases




in

Faulty probes are to blame for CDC coronavirus testing woes

The tests can still be used, CDC says, as urgency over possible outbreak grows




in

Simple synthesis for shapeshifting molecules

Bullvalene's constant metamorphosis could be exploited in sensing applications




in

Chemistry in Pictures: Crystals from outer space




in

European chemical firms face slowdown in industry

Results for 2019 show resilience, but coronavirus impact shadows forecasts for this year




in

US EPA finalizes list of 20 low-priority chemicals

Substances will not undergo further evaluation of health and safety risks at this time




in

Groups sue US military to stop PFAS incineration

Activists say contracts with companies violate federal law




in

Turning down the heat turns up better perovskites

Lower-temperature process improves the efficiency of single-crystal solar cells




in

Simple synthesis for shape-shifting molecules

Bullvalene's constant metamorphosis could be exploited in sensing applications




in

Researchers grow thin 2-D insulator on large scale

Single-crystal boron nitride could enable the use of 2-D materials for transistors in computer chips




in

Limiting global warming is getting harder, analysis says

Without policy changes, the gap between actual greenhouse gas emission reductions and those needed to hit climate targets will continue to widen




in

Faulty probes are to blame for CDC coronavirus testing woes

Early batches of the test can still be used, CDC says, while affirming it will deploy new kits




in

Chemistry in Pictures: Silver whiskers




in

Researchers in China report structure of the novel coronavirus bound to its human target

The structure shows the first steps of SARS-CoV-2 infection, and could help in drug discovery




in

Julie Zimmerman named editor in chief of &lt;i&gt;Environmental Science and Technology&lt;/i&gt;




in

Biogen to develop zinc finger therapies with Sangamo




in

First in vivo CRISPR gene editing in humans




in

Ingevity CEO Wilson resigns unexpectedly




in

AI finds molecules that kill bacteria, but would they make good antibiotics?

Experts praise the approach while remaining skeptical that the highlighted molecules could reach the clinic




in

BASF aims for 30% women in leadership




in

Genetic signature links bacterial toxin to colon cancer

Colibactin causes key cancer mutations




in

Sanofi creating new firm from its drug-making facilities

Venture will combine 6 active pharmaceutical ingredient production sites in Europe